{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:29:26Z","timestamp":1773786566760,"version":"3.50.1"},"reference-count":170,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Tinea cruris, a dermatophyte fungal infection predominantly caused by Trichophyton rubrum and Epidermophyton floccosum, primarily affects the groin, pubic region, and adjacent thigh. Its recurrence is frequent, attributable to repeated fungal infections in susceptible individuals, especially those with onychomycosis or tinea pedis, which act as reservoirs for dermatophytes. Given the persistent nature of tinea cruris, vaccination emerges as a promising strategy for fungal infection management, offering targeted, durable protection against various fungal species. Vaccines stimulate both humoral and cell-mediated immunity and are administered prophylactically to prevent infections while minimizing the risk of antifungal resistance development. Developing fungal vaccines is challenging due to the thick fungal cell wall, similarities between fungal and human cells, antigenic variation, and evolutionary resemblance to animals, complicating non-toxic target identification and T-cell response variability. No prior research has shown an mRNA vaccine for T. rubrum. Hence, this study proposes a novel mRNA-based vaccine for tinea cruris, potentially offering long-term immunity and reducing reliance on antifungal medications. This study explores the complete proteome of T. rubrum, identifying potential protein candidates for vaccine development through reverse vaccinology. Immunogenic epitopes from these candidates were mapped and integrated into multitope vaccines and reverse translated to construct mRNA vaccines. Then, the mRNA was translated and computationally assessed for physicochemical, chemical, and immunological attributes. Notably, 1,3-beta-glucanosyltransferase, CFEM domain-containing protein, cell wall galactomannoprotein, and LysM domain-containing protein emerged as promising vaccine targets. Antigenic, immunogenic, non-toxic, and non-allergenic cytotoxic T lymphocyte, helper T lymphocyte, and B lymphocyte epitopes were selected and linked with appropriate linkers and Toll-like receptor (TLR) agonist adjuvants to formulate vaccine candidates targeting T. rubrum. The protein-based vaccines underwent reverse translation to construct the mRNA vaccines, which, after inoculation, were translated again by host ribosomes to work as potential components for triggering the immune response. After that, molecular docking, normal mode analysis, and molecular dynamic simulation confirmed strong binding affinities and stable complexes between vaccines and TLR receptors. Furthermore, immune simulations of vaccines with and without adjuvant demonstrated activation of immune responses, evidenced by elevated levels of IgG1, IgG2, IgM antibodies, cytokines, and interleukins. There was no significant change in antibody production between vaccines with and without adjuvants, but adjuvants are crucial for activating the innate immune response via TLRs. Although mRNA vaccines hold promise against fungal infections, further research is essential to assess their safety and efficacy. Experimental validation is crucial for evaluating their immunogenicity, effectiveness, and safety.<\/jats:p>","DOI":"10.3390\/pharmaceutics16080983","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T11:43:44Z","timestamp":1721907824000},"page":"983","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Bioinformatics-Driven mRNA-Based Vaccine Design for Controlling Tinea Cruris Induced by Trichophyton rubrum"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7950-0785","authenticated-orcid":false,"given":"Amir","family":"Elalouf","sequence":"first","affiliation":[{"name":"Department of Management, Bar-Ilan University, Ramat Gan 5290002, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan","family":"Maoz","sequence":"additional","affiliation":[{"name":"Department of Management, Bar-Ilan University, Ramat Gan 5290002, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Rosenfeld","sequence":"additional","affiliation":[{"name":"Department of Management, Bar-Ilan University, Ramat Gan 5290002, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Khurana, A., Sardana, K., and Chowdhary, A. (2019). Antifungal Resistance in Dermatophytes: Recent Trends and Therapeutic Implications. Fungal Genet. Biol., 132.","DOI":"10.1016\/j.fgb.2019.103255"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/idoj.IDOJ_137_17","article-title":"Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre?","volume":"9","author":"Sardana","year":"2018","journal-title":"Indian Dermatol. Online J."},{"key":"ref_3","unstructured":"Bishnoi, A., and Mahajan, R. (2023). Tinea Cruris. Diagnostics to Pathogenomics of Sexually Transmitted Infections, John Wiley & Sons Ltd."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.37962\/jbas.v12i1.348","article-title":"Emergence of Antifungal Azole Resistance in the Fungal Strains of Tinea Corporis, Tinea Capitis, Tinea Cruris and Tinea Pedis from the Locality of Southern Punjab, Pakistan","volume":"12","author":"Ismail","year":"2021","journal-title":"RADS J. Biol. Res. Appl. Sci."},{"key":"ref_5","first-page":"484","article-title":"Prevalence of Dermatophytes in Superficial Skin Infections in a Tertiary Care Hospital","volume":"31","author":"Kashif","year":"2021","journal-title":"J. Pak. Assoc. Dermatol."},{"key":"ref_6","first-page":"1717","article-title":"Prevalence of Dermatophytes Fungal Infection among Different Gender","volume":"14","author":"Ahmed","year":"2020","journal-title":"Indian J. Forensic Med. Toxicol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/jamadermatol.2022.3745","article-title":"Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients with Tinea Corporis\/Cruris: A Randomized Clinical Trial","volume":"158","author":"Khurana","year":"2022","journal-title":"JAMA Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clindermatol.2009.12.005","article-title":"Epidemiology of Superficial Fungal Infections","volume":"28","author":"Ameen","year":"2010","journal-title":"Clin. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/2229-5178.178099","article-title":"Management of Tinea Corporis, Tinea Cruris, and Tinea Pedis: A Comprehensive Review","volume":"7","author":"Sahoo","year":"2016","journal-title":"Indian Dermatol. Online J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11046-016-0045-0","article-title":"New Antifungal Agents and New Formulations Against Dermatophytes","volume":"182","author":"Gupta","year":"2017","journal-title":"Mycopathologia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11684-017-0601-0","article-title":"Epidemiology of Fungal Infections in China","volume":"12","author":"Chen","year":"2018","journal-title":"Front. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.18231\/2581-4729.2018.0047","article-title":"Prevalence of Tinea Corporis and Tinea Cruris in Chitradurga Rural Population","volume":"4","author":"Girish","year":"2020","journal-title":"IP Indian J. Clin. Exp. Dermatol."},{"key":"ref_13","first-page":"133","article-title":"Tinea Cruris in Children","volume":"84","author":"Patel","year":"2009","journal-title":"Cutis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"31575","DOI":"10.1021\/acsomega.3c01988","article-title":"Superficial Dermatophytosis across the World\u2019s Populations: Potential Benefits from Nanocarrier-Based Therapies and Rising Challenges","volume":"8","author":"Keshwania","year":"2023","journal-title":"ACS Omega"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/bjd.13441","article-title":"Evidence-Based Topical Treatments for Tinea Cruris and Tinea Corporis: A Summary of a Cochrane Systematic Review","volume":"172","author":"Fedorowicz","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mijaljica, D., Spada, F., and Harrison, I.P. (2022). Emerging Trends in the Use of Topical Antifungal-Corticosteroid Combinations. J. Fungi, 8.","DOI":"10.3390\/jof8080812"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hay, R. (2018). Therapy of Skin, Hair and Nail Fungal Infections. J. Fungi, 4.","DOI":"10.3390\/jof4030099"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/QCO.0b013e32835ebcb7","article-title":"New Antifungal Antibiotics","volume":"26","author":"Paiva","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/idoj.IDOJ_281_17","article-title":"Newer Topical Treatments in Skin and Nail Dermatophyte Infections","volume":"9","author":"Sahni","year":"2018","journal-title":"Indian Dermatol. Online J."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Abdallah, B.M., Rajendran, P., and Ali, E.M. (2023). Potential Treatment of Dermatophyte Trichophyton rubrum in Rat Model Using Topical Green Biosynthesized Silver Nanoparticles with Achillea Santolina Extract. Molecules, 28.","DOI":"10.3390\/molecules28041536"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kumar, R., and Srivastava, V. (2023). Application of Anti-Fungal Vaccines as a Tool against Emerging Anti-Fungal Resistance. Front. Fungal Biol., 4.","DOI":"10.3389\/ffunb.2023.1241539"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mib.2020.09.007","article-title":"Immunotherapeutic Approaches for Fungal Infections","volume":"58","author":"Williams","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.coi.2014.01.014","article-title":"Vaccine Immunity against Fungal Infections","volume":"28","author":"Nanjappa","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101752","DOI":"10.1016\/j.smim.2023.101752","article-title":"Exploiting Antifungal Immunity in the Clinical Context","volume":"67","author":"Lionakis","year":"2023","journal-title":"Semin. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"In\u00e1cio, M.M., Moreira, A.L.E., Cruz-Leite, V.R.M., Mattos, K., Silva, L.O.S., Venturini, J., Ruiz, O.H., Ribeiro-Dias, F., Weber, S.S., and Soares, C.M.d.A. (2023). Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics. J. Fungi, 9.","DOI":"10.3390\/jof9060633"},{"key":"ref_26","unstructured":"(2024, April 12). The Last of Us Raises the Question: Why Don\u2019t We Have Vaccines for Fungal Infections?\u2014Vox. Available online: https:\/\/www.vox.com\/science-and-health\/2023\/2\/11\/23592955\/last-of-us-fungal-vaccines-infections-cordyceps."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial","volume":"66","author":"Edwards","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Da Silva, L.B.R., Taborda, C.P., and Nosanchuk, J.D. (2020). Advances in Fungal Peptide Vaccines. J. Fungi, 6.","DOI":"10.3390\/jof6030119"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00278-07","article-title":"An Anti-\u03b2-Glucan Monoclonal Antibody Inhibits Growth and Capsule Formation of Cryptococcus neoformans In Vitro and Exerts Therapeutic, Anticryptococcal Activity In Vivo","volume":"75","author":"Rachini","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mib.2012.04.004","article-title":"Recent Progress in Vaccines against Fungal Diseases","volume":"15","author":"Cassone","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41541-021-00294-8","article-title":"Vaccines for Human Fungal Diseases: Close but Still a Long Way to Go","volume":"6","author":"Oliveira","year":"2021","journal-title":"npj Vaccines"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/14712598.2017.1322576","article-title":"Promising Immunotherapy against Fungal Diseases","volume":"17","author":"Posch","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_33","first-page":"1397","article-title":"Characteristics of the Trichophyton Mentagrophytes F-01 Strain Used for the Manufacture of Biologics against Bovine Trichophyton OPEN ACCESS Citation","volume":"5","author":"Ba","year":"2022","journal-title":"World J. Surg. Surg. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41598-022-26567-3","article-title":"Development, Preparation, and Evaluation of a Novel Non-Adjuvanted Polyvalent Dermatophytes Vaccine","volume":"13","author":"Soliman","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"pgac248","DOI":"10.1093\/pnasnexus\/pgac248","article-title":"Immunogenicity and Protective Efficacy of a Pan-Fungal Vaccine in Preclinical Models of Aspergillosis, Candidiasis, and Pneumocystosis","volume":"1","author":"Rayens","year":"2022","journal-title":"PNAS Nexus"},{"key":"ref_36","unstructured":"Hataway, L. (2024, April 13). New Vaccine Targets Life-Threatening Fungal Infections. Available online: https:\/\/news.uga.edu\/new-vaccine-targets-fungal-infections\/."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Cerdeira, C., Molares-Vila, A., S\u00e1nchez-C\u00e1rdenas, C.D., Vel\u00e1squez-B\u00e1maca, J.S., and Mart\u00ednez-Herrera, E. (2023). Bioinformatics Approaches Applied to the Discovery of Antifungal Peptides. Antibiotics, 12.","DOI":"10.3390\/antibiotics12030566"},{"key":"ref_38","unstructured":"Avina, S. (2024, April 12). Breakthroughs and Challenges in Fungal Vaccine Development. Available online: https:\/\/asm.org\/articles\/2023\/november\/breakthroughs-and-challenges-in-fungal-vaccine-dev."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Basu, A. (2022). In Silico Epitope-Based Vaccine Prediction against Fungal Infection Aspergillosis. Challenges, 13.","DOI":"10.3390\/challe13020029"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Bidmos, F.A., Siris, S., Gladstone, C.A., and Langford, P.R. (2018). Bacterial Vaccine Antigen Discovery in the Reverse Vaccinology 2.0 Era: Progress and Challenges. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02315"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"a012476","DOI":"10.1101\/cshperspect.a012476","article-title":"Vaccines, Reverse Vaccinology, and Bacterial Pathogenesis","volume":"3","author":"Delany","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Elalouf, A., and Yaniv-Rosenfeld, A. (2023). Immunoinformatic-Guided Designing and Evaluating Protein and MRNA-Based Vaccines against Cryptococcus neoformans for Immunocompromised Patients. J. Genet. Eng. Biotechnol., 21.","DOI":"10.1186\/s43141-023-00560-3"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cmi.2017.92","article-title":"Multi-Epitope Vaccines: A Promising Strategy against Tumors and Viral Infections","volume":"15","author":"Zhang","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Nosrati, M., Behbahani, M., and Mohabatkar, H. (2019). Towards the First Multi-Epitope Recombinant Vaccine against Crimean-Congo Hemorrhagic Fever Virus: A Computer-Aided Vaccine Design Approach. J. Biomed. Inform., 93.","DOI":"10.1016\/j.jbi.2019.103160"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.meegid.2016.12.010","article-title":"Immunoinformatics Analysis and In Silico Designing of a Novel Multi-Epitope Peptide Vaccine against Staphylococcus aureus","volume":"48","author":"Hajighahramani","year":"2017","journal-title":"Infect. Genet. Evol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/biol.2001.0297","article-title":"The Development of Multi-Epitope Vaccines: Epitope Identification, Vaccine Design and Clinical Evaluation","volume":"29","author":"Sette","year":"2001","journal-title":"Biologicals"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2174\/1389201017666160914191106","article-title":"Harnessing Bioinformatics for Designing a Novel Multiepitope Peptide Vaccine Against Breast Cancer","volume":"17","author":"Mahmoodi","year":"2016","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Al Fayez, N., Nassar, M.S., Alshehri, A.A., Alnefaie, M.K., Almughem, F.A., Alshehri, B.Y., Alawad, A.O., and Tawfik, E.A. (2023). Recent Advancement in MRNA Vaccine Development and Applications. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15071972"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Gote, V., Bolla, P.K., Kommineni, N., Butreddy, A., Nukala, P.K., Palakurthi, S.S., and Khan, W. (2023). A Comprehensive Review of MRNA Vaccines. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032700"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"MRNA Vaccines\u2014A New Era in Vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/14760584.2024.2354251","article-title":"Research Progress on the Quality Control of MRNA Vaccines","volume":"23","author":"Hu","year":"2024","journal-title":"Expert Rev. Vaccines"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Chavda, V.P., Soni, S., Vora, L.K., Soni, S., Khadela, A., and Ajabiya, J. (2022). MRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines.","DOI":"10.3390\/vaccines10122150"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ymthe.2022.02.016","article-title":"COVID-19 MRNA Vaccines: Platforms and Current Developments","volume":"30","author":"Mahiny","year":"2022","journal-title":"Mol. Ther."},{"key":"ref_54","first-page":"269","article-title":"Cell Wall Antigens in Aspergillus fumigatus","volume":"24","author":"Latge","year":"1993","journal-title":"Arch. Med. Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Garcia-Rubio, R., de Oliveira, H.C., Rivera, J., and Trevijano-Contador, N. (2020). The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02993"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Gow, N.A.R., Latge, J.P., and Munro, C.A. (2017). The Fungal Cell Wall: Structure, Biosynthesis, and Function. Microbiol. Spectr., 5.","DOI":"10.1128\/microbiolspec.FUNK-0035-2016"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.femsim.2004.03.012","article-title":"Antibody Response to Candida albicans Cell Wall Antigens","volume":"41","author":"Casanova","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Kaur, G., Chawla, S., Kumar, P., and Singh, R. (2023). Advancing Vaccine Strategies against Candida Infections: Exploring New Frontiers. Vaccines, 11.","DOI":"10.3390\/vaccines11111658"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1002\/mco2.167","article-title":"MRNA Vaccines in the Prevention and Treatment of Diseases","volume":"3","author":"Gu","year":"2022","journal-title":"MedComm"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Doytchinova, I.A., and Flower, D.R. (2007). VaxiJen: A Server for Prediction of Protective Antigens, Tumour Antigens and Subunit Vaccines. BMC Bioinform., 8.","DOI":"10.1186\/1471-2105-8-4"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"W228","DOI":"10.1093\/nar\/gkac278","article-title":"DeepLoc 2.0: Multi-Label Subcellular Localization Prediction Using Protein Language Models","volume":"50","author":"Thumuluri","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_62","first-page":"62","article-title":"Coincidence of COVID-19 Epidemic and Olfactory Dysfunction Outbreak in Iran","volume":"34","author":"Bagheri","year":"2020","journal-title":"Med. J. Islam. Repub. Iran"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Naveed, M., Sheraz, M., Amin, A., Waseem, M., Aziz, T., Khan, A.A., Ghani, M., Shahzad, M., Alruways, M.W., and Dablool, A.S. (2022). Designing a Novel Peptide-Based Multi-Epitope Vaccine to Evoke a Robust Immune Response against Pathogenic Multidrug-Resistant Providencia Heimbachae. Vaccines, 10.","DOI":"10.3390\/vaccines10081300"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","article-title":"Predicting Transmembrane Protein Topology with a Hidden Markov Model: Application to Complete Genomes","volume":"305","author":"Krogh","year":"2001","journal-title":"J. Mol. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Walker, J.M. (2005). The Proteomics Protocols Handbook, Humana Press.","DOI":"10.1385\/1592598900"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"17626","DOI":"10.1038\/s41598-021-96863-x","article-title":"Identification of Vaccine Targets in Pathogens and Design of a Vaccine Using Computational Approaches","volume":"11","author":"Rawal","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e18623","DOI":"10.1016\/j.heliyon.2023.e18623","article-title":"Identification of Vaccine Candidates against Rhodococcus equi by Combining Pangenome Analysis with a Reverse Vaccinology Approach","volume":"9","author":"Liu","year":"2023","journal-title":"Heliyon"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M.R., Appel, R.D., and Bairoch, A. (2005). Protein Identification and Analysis Tools on the ExPASy Server. The Proteomics Protocols Handbook, Humana Press.","DOI":"10.1385\/1-59259-890-0:571"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"W521","DOI":"10.1093\/nar\/gkae241","article-title":"The EMBL-EBI Job Dispatcher Sequence Analysis Tools Framework in 2024","volume":"52","author":"Madeira","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/bioinformatics\/btaa1102","article-title":"SoluProt: Prediction of Soluble Protein Expression in Escherichia coli","volume":"37","author":"Hon","year":"2021","journal-title":"Bioinformatics"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Fleri, W., Paul, S., Dhanda, S.K., Mahajan, S., Xu, X., Peters, B., and Sette, A. (2017). The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00278"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: Improved Predictions of MHC Antigen Presentation by Concurrent Motif Deconvolution and Integration of MS MHC Eluted Ligand Data","volume":"48","author":"Reynisson","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/bioinformatics\/btg108","article-title":"ProPred1: Prediction of Promiscuous MHC Class-I Binding Sites","volume":"19","author":"Singh","year":"2003","journal-title":"Bioinformatics"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Sharma, N., Naorem, L.D., Jain, S., and Raghava, G.P.S. (2022). ToxinPred2: An Improved Method for Predicting Toxicity of Proteins. Brief. Bioinform., 23.","DOI":"10.1093\/bib\/bbac174"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Calis, J.J.A., Maybeno, M., Greenbaum, J.A., Weiskopf, D., De Silva, A.D., Sette, A., Ke\u015fmir, C., and Peters, B. (2013). Properties of MHC Class I Presented Peptides That Enhance Immunogenicity. PLoS Comput. Biol., 9.","DOI":"10.1371\/journal.pcbi.1003266"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v.2\u2014A Server for in Silico Prediction of Allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/bioinformatics\/17.12.1236","article-title":"ProPred: Prediction of HLA-DR Binding Sites","volume":"17","author":"Singh","year":"2002","journal-title":"Bioinformatics"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"srep42851","DOI":"10.1038\/srep42851","article-title":"Computer-Aided Designing of Immunosuppressive Peptides Based on IL-10 Inducing Potential","volume":"7","author":"Nagpal","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Dhanda, S.K., Vir, P., and Raghava, G.P.S. (2013). Designing of Interferon-Gamma Inducing MHC Class-II Binders. Biol. Direct, 8.","DOI":"10.1186\/1745-6150-8-30"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"263952","DOI":"10.1155\/2013\/263952","article-title":"Prediction of IL4 Inducing Peptides","volume":"2013","author":"Dhanda","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"W24","DOI":"10.1093\/nar\/gkx346","article-title":"BepiPred-2.0: Improving Sequence-Based B-Cell Epitope Prediction Using Conformational Epitopes","volume":"45","author":"Jespersen","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/978-1-60327-118-9_29","article-title":"Prediction Methods for B-Cell Epitopes","volume":"409","author":"Saha","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of Continuous B-Cell Epitopes in an Antigen Using Recurrent Neural Network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins Struct. Funct. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Bui, H.H., Sidney, J., Li, W., Fusseder, N., and Sette, A. (2007). Development of an Epitope Conservancy Analysis Tool to Facilitate the Design of Epitope-Based Diagnostics and Vaccines. BMC Bioinform., 8.","DOI":"10.1186\/1471-2105-8-361"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Sanches, R.C.O., Tiwari, S., Ferreira, L.C.G., Oliveira, F.M., Lopes, M.D., Passos, M.J.F., Maia, E.H.B., Taranto, A.G., Kato, R., and Azevedo, V.A.C. (2021). Immunoinformatics Design of Multi-Epitope Peptide-Based Vaccine Against Schistosoma Mansoni Using Transmembrane Proteins as a Target. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.621706"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"24485","DOI":"10.1038\/s41598-021-03932-2","article-title":"Designing a Multi-Epitope Vaccine to Provoke the Robust Immune Response against Influenza A H7N9","volume":"11","author":"Tarrahimofrad","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s10989-022-10438-6","article-title":"Exploratory Algorithm of a Multi-Epitope-Based Subunit Vaccine Candidate against Cryptosporidium hominis: Reverse Vaccinology-Based Immunoinformatic Approach","volume":"28","author":"Hasan","year":"2022","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/s41598-020-57906-x","article-title":"In Silico Design of a Multivalent Vaccine Against Candida albicans","volume":"10","author":"Tarang","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1021\/acs.molpharmaceut.5b00802","article-title":"Intranasal Vaccination against HIV-1 with Adenoviral Vector-Based Nanocomplex Using Synthetic TLR-4 Agonist Peptide as Adjuvant","volume":"13","author":"Li","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Shanmugam, A., Rajoria, S., George, A.L., Mittelman, A., Suriano, R., and Tiwari, R.K. (2012). Synthetic Toll like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030839"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.virol.2016.04.027","article-title":"Novel 6xHis Tagged Foot-and-Mouth Disease Virus Vaccine Bound to Nanolipoprotein Adjuvant via Metal Ions Provides Antigenic Distinction and Effective Protective Immunity","volume":"495","author":"Rai","year":"2016","journal-title":"Virology"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Mukhtar, M., Wajeeha, A.W., us Sahar Sadaf Zaidi, N., and Bibi, N. (2022). Engineering Modified MRNA-Based Vaccine against Dengue Virus Using Computational and Reverse Vaccinology Approaches. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213911"},{"key":"ref_93","first-page":"422","article-title":"In Silico Design and Evaluation of a Novel MRNA Vaccine against BK Virus: A Reverse Vaccinology Approach","volume":"1","author":"Mohammadi","year":"2022","journal-title":"Immunol. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1038\/s41598-022-08506-4","article-title":"Novel In Silico MRNA Vaccine Design Exploiting Proteins of M. Tuberculosis That Modulates Host Immune Responses by Inducing Epigenetic Modifications","volume":"12","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1080\/07391102.2022.2119280","article-title":"Design and In Silico Analysis of MRNA Vaccine Construct against Salmonella","volume":"41","author":"Imdad","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"W526","DOI":"10.1093\/nar\/gki376","article-title":"JCat: A Novel Tool to Adapt Codon Usage of a Target Gene to Its Potential Expression Host","volume":"33","author":"Grote","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.1073\/pnas.0401799101","article-title":"Incorporating Chemical Modification Constraints into a Dynamic Programming Algorithm for Prediction of RNA Secondary Structure","volume":"101","author":"Mathews","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Lorenz, R., Bernhart, S.H., H\u00f6ner zu Siederdissen, C., Tafer, H., Flamm, C., Stadler, P.F., and Hofacker, I.L. (2011). ViennaRNA Package 2.0. Algorithms Mol. Biol., 6.","DOI":"10.1186\/1748-7188-6-26"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"W70","DOI":"10.1093\/nar\/gkn188","article-title":"The Vienna RNA Websuite","volume":"36","author":"Gruber","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1038\/s41467-023-42528-4","article-title":"TrRosettaRNA: Automated Prediction of RNA 3D Structure with Transformer Network","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C., and Thakur, A. (2020). Opportunities and Challenges in the Delivery of Mrna-Based Vaccines. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12020102"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","article-title":"High-throughput prediction of protein antigenicity using protein microarray data","volume":"26","author":"Magnan","year":"2010","journal-title":"Bioinformatics"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/bioinformatics\/11.6.681","article-title":"Sopma: Significant Improvements in Protein Secondary Structure Prediction by Consensus Prediction from Multiple Alignments","volume":"11","author":"Geourjon","year":"1995","journal-title":"Bioinform."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/bioinformatics\/16.4.404","article-title":"The PSIPRED Protein Structure Prediction Server","volume":"16","author":"McGuffin","year":"2000","journal-title":"Bioinformatics"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: Making Protein Folding Accessible to All","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat. Methods"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"W294","DOI":"10.1093\/nar\/gks493","article-title":"GalaxyWEB Server for Protein Structure Prediction and Refinement","volume":"40","author":"Ko","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Laskowski, R.A., MacArthur, M.W., and Thornton, J.M. (2012). PROCHECK: Validation of Protein-Structure Coordinates. International Tables of Crystallography, Volume F. Crystallography of Biological Macromolecules, John Wiley & Sons, Ltd.","DOI":"10.1107\/97809553602060000882"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Ponomarenko, J., Bui, H.H., Li, W., Fusseder, N., Bourne, P.E., Sette, A., and Peters, B. (2008). ElliPro: A New Structure-Based Tool for the Prediction of Antibody Epitopes. BMC Bioinformatics, 9.","DOI":"10.1186\/1471-2105-9-514"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.micinf.2004.08.014","article-title":"Interactions of Toll-like Receptors with Fungi","volume":"6","author":"Levitz","year":"2004","journal-title":"Microbes Infect."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Masure, D., Vlaminck, J., Wang, T., Chiers, K., Van den Broeck, W., Vercruysse, J., and Geldhof, P. (2013). A Role for Eosinophils in the Intestinal Immunity against Infective Ascaris Suum Larvae. PLoS Neglected Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002138"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Nogueira, D.S., De Oliveira, L.M., Amorim, C.C.O., Gazzinelli-Guimaraes, A.C., Barbosa, F.S., Oliveira, F.M.S., Kraemer, L., Mattos, M., Cardoso, M.S., and Resende, N.M. (2021). Eosinophils Mediate SIgA Production Triggered by TLR2 and TLR4 to Control Ascaris Suum Infection in Mice. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1010067"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro Web Server for Protein-Protein Docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/prot.25219","article-title":"New Additions to the ClusPro Server Motivated by CAPRI","volume":"85","author":"Vajda","year":"2017","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.str.2020.06.006","article-title":"Performance and Its Limits in Rigid Body Protein-Protein Docking","volume":"28","author":"Desta","year":"2020","journal-title":"Structure"},{"key":"ref_115","first-page":"154","article-title":"In Silico Molecular Docking Analysis of Limonene with The Fat Mass and Obesity-Associated Protein by Using Autodock Vina","volume":"8","author":"Ahmed","year":"2021","journal-title":"Sci. J. Inform."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","article-title":"PRODIGY: A Web Server for Predicting the Binding Affinity of Protein-Protein Complexes","volume":"32","author":"Xue","year":"2016","journal-title":"Bioinformatics"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e07454","DOI":"10.7554\/eLife.07454","article-title":"Contacts-Based Prediction of Binding Affinity in Protein\u2013Protein Complexes","volume":"4","author":"Vangone","year":"2015","journal-title":"Elife"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0968-0004(97)01140-7","article-title":"PDBsum: A Web-Based Database of Summaries and Analyses of All PDB Structures","volume":"22","author":"Laskowski","year":"1997","journal-title":"Trends Biochem. Sci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"W271","DOI":"10.1093\/nar\/gku339","article-title":"IMODS: Internal Coordinates Normal Mode Analysis Server","volume":"42","author":"Aliaga","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Bowers, K.J., Chow, E., Xu, H., Dror, R.O., Eastwood, M.P., Gregersen, B.A., Klepeis, J.L., Kolossvary, I., Moraes, M.A., and Sacerdoti, F.D. (2006, January 11\u201317). Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters. Proceedings of the Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing, SC\u201906, Tampa, FL, USA.","DOI":"10.1109\/SC.2006.54"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4155\/fmc.15.21","article-title":"Target-Based Molecular Modeling Strategies for Schistosomiasis Drug Discovery","volume":"7","author":"Ferreira","year":"2015","journal-title":"Future Med. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Ferreira, L.G., Dos Santos, R.N., Oliva, G., and Andricopulo, A.D. (2015). Molecular Docking and Structure-Based Drug Design Strategies. Molecules, 20.","DOI":"10.3390\/molecules200713384"},{"key":"ref_123","first-page":"55","article-title":"Computational Analysis of Action Mechanism and Evolutionary Computational Analysis of Action Mechanism and Evolutionary Insight of Chitin Degrading Enzymes in Bacillus cereus","volume":"67","author":"Ahmed","year":"2024","journal-title":"J. Xi\u2019an Shiyou Univ. Nat. Sci. Ed."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.tibs.2019.06.004","article-title":"Bringing Molecular Dynamics Simulation Data into View","volume":"44","author":"Hildebrand","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Rasheed, M.A., Iqbal, M.N., Saddick, S., Ali, I., Khan, F.S., Kanwal, S., Ahmed, D., Ibrahim, M., Afzal, U., and Awais, M. (2021). Identification of Lead Compounds against Scm (Fms10) in Enterococcus Faecium Using Computer Aided Drug Designing. Life, 11.","DOI":"10.3390\/life11020077"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of Absolute Solvation Free Energies Using Molecular Dynamics Free Energy Perturbation and the Opls Force Field","volume":"6","author":"Shivakumar","year":"2010","journal-title":"J. Chem. Theory Comput."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery","volume":"7","author":"Meng","year":"2012","journal-title":"Curr. Comput. Aided-Drug Des."},{"key":"ref_128","unstructured":"Castiglione, F., and Bernaschi, M. (2004, January 5\u20139). C-Immsim: Playing with the Immune Response. Proceedings of the 16th International Symposium on Mathematical Theory of Networks and Systems (MTNS2004), Leuven, Belgium."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s43141-023-00574-x","article-title":"Computational Design and Evaluation of MRNA- and Protein-Based Conjugate Vaccines for Influenza A and SARS-CoV-2 Viruses","volume":"21","author":"Elalouf","year":"2023","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.semcdb.2018.03.003","article-title":"Pattern Recognition Receptors in Fungal Immunity","volume":"89","author":"Patin","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41467-019-08950-3","article-title":"A Small Secreted Protein Triggers a TLR2\/4-Dependent Inflammatory Response during Invasive Candida albicans Infection","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Duan, T., Du, Y., Xing, C., Wang, H.Y., and Wang, R.F. (2022). Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity, Frontiers Media SA.","DOI":"10.3389\/fimmu.2022.812774"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/14760584.2020.1794832","article-title":"An Overview of In Silico Vaccine Design against Different Pathogens and Cancer","volume":"19","author":"Kardani","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s10989-019-09918-z","article-title":"Epitope Prediction by Novel Immunoinformatics Approach: A State-of-the-Art Review","volume":"26","author":"Raoufi","year":"2020","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal Co-Infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China","volume":"185","author":"Song","year":"2020","journal-title":"Mycopathologia"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"105872","DOI":"10.1016\/j.intimp.2019.105872","article-title":"Production, Purification, and In Vivo Evaluation of a Novel Multiepitope Peptide Vaccine Consisted of Immunodominant Epitopes of SYCP1 and ACRBP Antigens as a Prophylactic Melanoma Vaccine","volume":"76","author":"Safavi","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"16258","DOI":"10.1038\/s41598-020-73179-w","article-title":"In Silico Analysis and In Vivo Assessment of a Novel Epitope-Based Vaccine Candidate against Uropathogenic Escherichia coli","volume":"10","author":"Hasanzadeh","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/omi.2019.0183","article-title":"Design of Staphylococcus aureus New Vaccine Candidates with B and T Cell Epitope Mapping, Reverse Vaccinology, and Immunoinformatics","volume":"24","author":"Soltan","year":"2020","journal-title":"OMICS A J. Integr. Biol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Pan, X., Ke, H., Niu, X., Li, S., Lv, J., and Pan, L. (2018). Protection against Helicobacter Pylori Infection in BALB\/c Mouse Model by Oral Administration of Multivalent Epitope-Based Vaccine of Cholera Toxin B Subunit-HUUC. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01003"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1371\/journal.pntd.0005927","article-title":"Recombinant Vaccines of a CD4+T-Cell Epitope Promote Efficient Control of Paracoccidioides Brasiliensis Burden by Restraining Primary Organ Infection","volume":"11","author":"Holanda","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"249","DOI":"10.18231\/j.ijced.2023.048","article-title":"Difficult to Treat Superficial Fungal Infections: Which Factors One Should Consider in Clinical Practice\u2014An Indian Perspective","volume":"9","author":"Trailokya","year":"2023","journal-title":"IP Indian J. Clin. Exp. Dermatol."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Ahmed, M.Z., Rao, T., Saeed, A., Mutahir, Z., Hameed, S., Inayat, S., Shahzad, H., Ullah, N., Abaid-Ullah, M., and Ibrahim, M. (2021). Antifungal Drugs: Mechanism of Action and Resistance. Biochemistry of Drug Resistance, Springer International Publishing.","DOI":"10.1007\/978-3-030-76320-6_5"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Ahmed, S., Ahmed, M.Z., Rafique, S., Almasoudi, S.E., Shah, M., Jalil, N.A.C., and Ojha, S.C. (2023). Recent Approaches for Downplaying Antibiotic Resistance: Molecular Mechanisms. Biomed. Res. Int., 2023.","DOI":"10.1155\/2023\/5250040"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.ASW.0000569128.44287.67","article-title":"Diagnosis and Management of Cutaneous Tinea Infections","volume":"32","author":"Woo","year":"2019","journal-title":"Adv. Ski. Wound Care"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Mouyna, I., Hartl, L., and Latg\u00e9, J.P. (2013). \u03b2-1,3-Glucan Modifying Enzymes in Aspergillus fumigatus. Front. Microbiol., 4.","DOI":"10.3389\/fmicb.2013.00081"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Lee, D.J., O\u2019Donnell, H., Routier, F.H., Tiralongo, J., and Haselhorst, T. (2019). Glycobiology of Human Fungal Pathogens: New Avenues for Drug Development. Cells, 8.","DOI":"10.3390\/cells8111348"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Yoshimi, A., Miyazawa, K., and Abe, K. (2017). Function and Biosynthesis of Cell Wall \u03b1-1,3-Glucan in Fungi. J. Fungi, 3.","DOI":"10.3390\/jof3040063"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Qian, Y., Zheng, X., Wang, X., Yang, J., Zheng, X., Zeng, Q., Li, J., Zhuge, Q., and Xiong, Q. (2022). Systematic Identification and Functional Characterization of the CFEM Proteins in Poplar Fungus Marssonina brunnea. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.1045615"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Huang, Z., Zhou, Y., Li, H., Bao, Y., Duan, Z., Wang, C., Powell, C.A., Wang, K., Hu, Q., and Chen, B. (2023). Identification of Common Fungal Extracellular Membrane (CFEM) Proteins in Fusarium sacchari That Inhibit Plant Immunity and Contribute to Virulence. Microbiol. Spectr., 11.","DOI":"10.1128\/spectrum.01452-23"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0968-0004(03)00025-2","article-title":"An Eight-Cysteine-Containing CFEM Domain Unique to a Group of Fungal Membrane Proteins","volume":"28","author":"Kulkarni","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Zhu, W., Wei, W., Wu, Y., Zhou, Y., Peng, F., Zhang, S., Chen, P., and Xu, X. (2017). BcCFEM1, a CFEM Domain-Containing Protein with Putative GPI-Anchored Site, Is Involved in Pathogenicity, Conidial Production, and Stress Tolerance in Botrytis Cinerea. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.01807"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1111\/1462-2920.16032","article-title":"Systematic Contributions of CFEM Domain-Containing Proteins to Iron Acquisition Are Essential for Interspecies Interaction of the Filamentous Pathogenic Fungus Beauveria bassiana","volume":"24","author":"Peng","year":"2022","journal-title":"Environ. Microbiol."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Muszewska, A., Pi\u0142syk, S., Perli\u0144ska-Lenart, U., and Kruszewska, J.S. (2018). Diversity of Cell Wall Related Proteins in Human Pathogenic Fungi. J. Fungi, 4.","DOI":"10.3390\/jof4010006"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"44418","DOI":"10.1074\/jbc.M112.398321","article-title":"Biosynthesis of the Fungal Cell Wall Polysaccharide Galactomannan Requires Intraluminal GDP-Mannose","volume":"287","author":"Engel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1093\/plphys\/kiac391","article-title":"Fungal Dual-Domain LysM Effectors Undergo Chitin-Induced Intermolecular, and Not Intramolecular, Dimerization","volume":"190","author":"Tian","year":"2022","journal-title":"Plant Physiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1038\/s41598-019-40039-1","article-title":"Characterisation of Novel-Cell-Wall LysM-Domain Proteins LdpA and LdpB from the Human Pathogenic Fungus Aspergillus fumigatus","volume":"9","author":"Muraosa","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Chen, Q., Dong, C., Sun, X., Zhang, Y., Dai, H., and Bai, S. (2020). Overexpression of an Apple LysM-Containing Protein Gene, MdCERK1-2, Confers Improved Resistance to the Pathogenic Fungus, Alternaria alternata, in Nicotiana benthamiana. BMC Plant Biol., 20.","DOI":"10.1186\/s12870-020-02361-z"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Kombrink, A., and Thomma, B.P.H.J. (2013). LysM Effectors: Secreted Proteins Supporting Fungal Life. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003769"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Suarez-Fernandez, M., Aragon-Perez, A., Lopez-Llorca, L.V., and Lopez-Moya, F. (2021). Putative Lysm Effectors Contribute to Fungal Lifestyle. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22063147"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/bioinformatics\/btv674","article-title":"Accurate Estimation of Isoelectric Point of Protein and Peptide Based on Amino Acid Sequences","volume":"32","author":"Audain","year":"2016","journal-title":"Bioinformatics"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"22387","DOI":"10.1038\/s41598-020-79645-9","article-title":"In Silico Discovery of Antigenic Proteins and Epitopes of SARS-CoV-2 for the Development of a Vaccine or a Diagnostic Approach for COVID-19","volume":"10","author":"Can","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41598-024-52457-x","article-title":"Identification and Prioritisation of Potential Vaccine Candidates Using Subtractive Proteomics and Designing of a Multi-Epitope Vaccine against Wuchereria bancrofti","volume":"14","author":"Aarthy","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Bai, X., Peng, H., Goher, F., Islam, M.A., Xu, S., Guo, J., Kang, Z., and Guo, J. (2022). A Candidate Effector Protein PstCFEM1 Contributes to Virulence of Stripe Rust Fungus and Impairs Wheat Immunity. Stress Biol., 2.","DOI":"10.1007\/s44154-022-00042-5"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.1038\/s41598-022-11851-z","article-title":"Designing a Novel Multi-epitope Vaccine against Ebola Virus Using Reverse Vaccinology Approach","volume":"12","author":"Alizadeh","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-55372-3","article-title":"Proteomics-Based Vaccine Targets Annotation and Design of Multi-Epitope Vaccine against Antibiotic-Resistant Streptococcus gallolyticus","volume":"14","author":"Chao","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1080\/07391102.2020.1850357","article-title":"Design of a Multi-Epitope-Based Vaccine Targeting M-Protein of SARS-CoV-2: An Immunoinformatics Approach","volume":"40","author":"Ayyagari","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/jgid.jgid_96_21","article-title":"Epitope Identification and Designing a Potent Multi-Epitope Vaccine Construct against SARS-CoV-2 Including the Emerging Variants","volume":"14","author":"Srinivasan","year":"2022","journal-title":"J. Glob. Infect. Dis."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-065X.2010.00978.x","article-title":"Use of Defined TLR Ligands as Adjuvants within Human Vaccines","volume":"239","author":"Duthie","year":"2011","journal-title":"Immunol. Rev."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Luchner, M., Reinke, S., and Milicic, A. (2021). Tlr Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020142"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Do, K.T.H., Willenzon, S., Ristenpart, J., Janssen, A., Volz, A., Sutter, G., F\u00f6rster, R., and Bo\u0161njak, B. (2023). The Effect of Toll-like Receptor Agonists on the Immunogenicity of MVA-SARS-2-S Vaccine after Intranasal Administration in Mice. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1259822"}],"updated-by":[{"DOI":"10.3390\/pharmaceutics16101273","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000}}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/8\/983\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T14:40:56Z","timestamp":1754232056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/8\/983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":170,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["pharmaceutics16080983"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics16080983","relation":{"correction":[{"id-type":"doi","id":"10.3390\/pharmaceutics16101273","asserted-by":"object"}]},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]}}}